Trial Profile
Pilot Study of First Line Combination Treatment With Low Dose Pegylated Interferon and Entecavir in Treatment-naive Patients With Chronic Hepatitis B.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Peginterferon (Primary)
- Indications Hepatitis B
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 08 May 2012 New trial record